N ot a m e m b e r ? J o i n at a s so c iate d h a i rp rofe s sio n a ls .c o m 45
19. Arthur C. Macedo, Andre O. V. de Faria, and Pietro
Ghezzi, "Boosting the Immune System, from Science
to Myth: Analysis of the Infosphere with Google,"
Frontiers in Medicine, July 2019, https://doi.org/10.3389/
fmed.2019.00165; Beverly Merz, "What Can You Do
to Improve Your Immune System?," Harvard Health
Publishing, September 2016, www.health.harvard.edu/
healthy-eating/what-can-you-do-to-improve-your-
immune-system; National Institute of Allergy and
Infectious Diseases, "Immune System Research: Overview
of the Immune System," last reviewed December 2013,
www.niaid.nih.gov/research/immune-system-overview.
20. National Cancer Institute, "CA M for Health
Professionals: High-Dose Vitamin-C PDQ—Health
Professional Version," updated February 14 2020, www.
cancer.gov/about-cancer/treatment/cam/hp/vitamin-c-
pdq.
21. Paul G. Auwaerter, "Coronavirus COV ID-19 (SARS-
CoV-2)."
22. Irani Thevarajan et al., "Breadth of Concomitant
Immune Responses Prior to Patient Recovery: A Case
Report of Non-Severe COV ID-19," Nature Medicine 26
(March 2020): 453–455, https://doi.org/10.1038/s41591-
020-0819-2; Puja Mehta et al., "COV ID-19: Consider
Cytokine Storm Syndromes and Immunosuppression,"
The Lancet 395, no. 10229 (March 2020): 1033–34, https://
doi.org/10.1016/S0140-6736(20)30628-0. Note that both
sources are in the form of peer-reviewed correspondence
reflecting the ongoing developments and uncertainty
within the medical community.
23. Mary Van Beusekom, "Study: COV ID-19 May Spread
in Several Different Ways," CIDR AP News, March 2020,
www.cidrap.umn.edu/news-perspective/2020/03/study-
covid-19-may-spread-several-different-ways.
24. Wenling Wang et al., "Detection of SARS-CoV-2 in
Different Types of Clinical Specimens," JAMA, March
2020, https://doi.org/10.1001/jama.2020.3786; Neeltje van
Doremalen et al., "Aerosol and Surface Stability of SARS-
CoV-2 as Compared with SARS CoV-1," New England
Journal of Medicine, March 2020, https://doi.org/10.1056/
NEJMc2004973.
25. American National Red Cross, "What to Know about
the Coronavirus and Blood Donation," 2020, www.
redcrossblood.org/donate-blood/dlp/coronavirus--covid-
19--and-blood-donation.html.
26. Hassan K. Siddiqi and Mandeep R. Mehra, "COV ID-19
Illness in Native and Immunosuppressed States: A
Clinical-Therapeutic Staging Proposal," Journal of
Heart and Lung Transplantation, preprint accessed March
2020, https://doi.org/10.1016/j.healun.2020.03.012; Lisa
Rosenbaum, "Facing Covid-19 in Italy—Ethics, Logistics,
and Therapeutics on the Epidemic's Front Line,"
New England Journal of Medicine, March 2020, https://
doi.org/10.1056/NEJMp2005492; Robert D. Truog,
Christine Mitchell, and George Q. Daley, "The Toughest
Triage—Allocating Ventilators in a Pandemic," New
England Journal of Medicine, March 2020, https://doi.
org/10.1056/NEJMp2005689; Ezekiel J. Emanuel et al.,
"Fair Allocation of Scarce Medical Resources in the Time
of Covid-19," New England Journal of Medicine, March
2020, https://doi.org/10.1056/NEJMsb2005114.
27. Jia Liu et al., "Hydroxychloroquine, a Less Toxic
Derivative of Chloroquine is Effective in Inhibiting
SARS-CoV-2 Infection In Vitro," Cell Discovery 6, no. 16
(March 2020), https://doi.org/10.1038/s41421-020-0156-0.
28. Phillippe Colson et al., "Chloroquine and
Hydroxychloroquine as Available Weapons to Fight
COV ID-19," International Journal of Antimicrobial
Agents, preprint accessed March 2020, https://doi.
org/10.1016/j.ijantimicag.2020.105932; Phillippe Gautret
et al., "Hydroxychloroquine and Azithromycin as a
Treatment of COV ID-19: Results of an Open-Label
Non-Randomized Clinical Trial," International Journal
of Antimicrobial Agents, preprint accessed March 2020,
https://doi.org/10.1016/j.ijantimicag.2020.105949;
Chen Jun et al., "A Pilot Study of Hydroxychloroquine
in Treatment of Patients with Common Coronavirus
Disease-19 (COV ID-19)," Journal of Zhejiang University,
49, no. 2 (March 2020): 215–219, https://doi.org/10.3785/j.
issn.1008-9292.2020.03.03; Paul Elias Alexander et
al, "COV ID-19 Coronavirus Research Has Overall
Low Methodological Quality Thus Far: Case in
Point for Chloroquine Hydroxychloroquine," Journal
of Clinical Epidemiology, April 18, 2020, https://doi.
org/10.1016/j.jclinepi.2020.04.016; ClinicalTrials.gov,
"Chloroquine Diphosphate in the Prevention of SARS
in Covid-19 Infection (CloroCOV ID19II)," updated
April 14, 2020, https://clinicaltrials.gov/ct2/show/
NCT04342650?term=NCT04342650&draw=2&rank=1.
29. Bin Cao et al., "A Trial of Lopinavir-Ritonavir in Adults
Hospitalized with Severe Covid-19," New England
Journal of Medicine, March 2020, https://doi.org/10.1056/
NEJMoa2001282.
30. Sandro G. Viveiros Rosa and Wilson C. Santos, "Clinical
Trials on Drug Repositioning For COV ID-19 Treatment,"
Pan American Journal of Public Health 2020, no. 44 (March
2020): e40, https://doi.org/10.26633/RPSP.2020.40;
James M Sanders et al, "Pharmacologic Treatments for
Coronavirus Disease 2019 (COV ID-19): A Review," JAMA
323, no. 18 (April 2020): 1824 –36, https://doi.org/10.1001/
jama.2020.6019.
31. International Committee of Medical Journal Editors,
"Recommendations for the Conduct, Reporting,
Editing, and Publication of Scholarly Work in Medical
Journals," ICMJE, December 2019, www.icmje.org/icmje-
recommendations.pdf.
32. Alonso Soto, "Nigeria Has Chloroquine Poisonings after
Trump Praised Drug," Bloomberg, March 2020, www.
bloomberg.com/news/articles/2020-03-21/nigeria-reports-
chloroquine-poisonings-after-trump-praised-drug; ABC
News, "Valley Man Dies, Wife Hospitalized after Taking
Chemicals to Protect Them from Coronavirus," ABC
News, March 23, 2020, www.abc15.com/news/state/valley-
man-dies-wife-hospitalized-after-taking-chemicals-to-
protect-from-coronavirus.
33. Adam Rogers, "Blood From COV ID-19 Survivors May
Point the Way to a Cure," Wired, March 24, 2020, www.
wired.com/story/an-old-source-for-potential-new-covid-
19-drugs-blood-serum; Arturo Casadevall and Liise-anne
Pirofski, "The Convalescent Sera Option for Containing
COV ID-19," Journal of Clinical Investigation 130, no. 4
(April 2020): 1545–48, https://doi.org/10.1172/JCI138003.
